150 likes | 256 Vues
This study examines prescription trends of antihypertensive agents in hemodialysis patients across different countries and their associations with patient characteristics and survival rates. The research assesses the prevalence of antihypertensive prescription, patient demographics, and the impact on all-cause and cardiovascular mortality.
E N D
Prescription of antihypertensive agents to hemodialysis patients: Time trends and associations with patient characteristics, country, and survival in the DOPPS
Prevalence of AHA Prescription in Prevalent Samples from Countries that Participated in Both Phases of DOPPS
Patient Characteristics by Any AHA in a cross-section of DOPPS I and DOPPS II (1)
Patient Characteristics by Any AHA in a cross-section of DOPPS I and DOPPS II (2)
Prevalence of AHA prescription by country, in a cross section of DOPPS II
Adjusted RR (95% CI)* of All-cause Mortality Associated with each Class of AHA
Adjusted RR (95% CI)* of Cardiovascular Mortality associated with each AHA